D. Gavish

发表

Hypolipidemic therapy modulates expression of apolipoprotein B epitopes on low density lipoproteins. Studies in mild to moderate hypertriglyceridemic patients.

G. Schonfeld, S. Eisenberg, Y. Kleinman, 1987, Journal of lipid research.

9-cis beta-carotene-rich powder of the alga Dunaliella bardawil increases plasma HDL-cholesterol in fibrate-treated patients.

Z. Rotstein, D. Harats, A. Ben‐Amotz, 2006, Atherosclerosis.

Comparison of short-term renal effects and efficacy of rosuvastatin 40 mg and simvastatin 80 mg, followed by assessment of long-term renal effects of rosuvastatin 40 mg, in patients with dyslipidemia.

H. Hauner, A. Marais, E. Stein, 2007, Journal of clinical lipidology.

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

I. Shapira, D. Schwartz, C. Kaplan, 2000, Journal of the American College of Cardiology.

Medical history of hypercholesterolaemia adversely affects the outcome of out-of-hospital cardiopulmonary resuscitation; the 'Shahal' experience in Israel.

I. Shapira, S. Laniado, A. Roth, 2000, European heart journal.

Relation of Adiponectin to Glucose Tolerance Status, Adiposity, and Cardiovascular Risk Factor Load

M. Boaz, M. Shargorodsky, Z. Matas, 2011, Experimental diabetes research.

Diurnal changes in plasma lipoproteins of free-living healthy men consuming a standard diet.

D. Gavish, M. Fainaru, Y. Skurnik, 1994, Israel journal of medical sciences.

Hemoglobin A1C as a prognostic factor and the pre-diabetic paradox in patients admitted to a tertiary care medical center intensive cardiac care unit

M. Glikson, E. Asher, L. Lupu, 2022, Cardiovascular Diabetology.

Efficacy of atorvastatin in treating high risk patients to reach low density lipoprotein-cholesterol goals: the Treat to Target (TTT-Israel) Study.

D. Harats, D. Gavish, E. Leibovitz, 2002, The Israel Medical Association journal : IMAJ.

Effect of angiotensin II receptor blockers, candesartan, on osteoprotegerin level in hypertensive patients: Link between bone and RAAS

M. Shargorodsky, D. Gavish, H. Oz, 2015, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Vascular Elasticity of Systemic Lupus Erythematosus Patients Is Associated with Steroids and Hydroxychloroquine Treatment

R. Zimlichman,, D. Gavish, E. Leibovitz, 2007, Annals of the New York Academy of Sciences.

Treatment with amlodipine and atorvastatin have additive effect in improvement of arterial compliance in hypertensive hyperlipidemic patients.

R. Zimlichman,, M. Shargorodsky, D. Gavish, 2003, American journal of hypertension.

Risk factor profile and achievement of treatment goals among hypertensive patients in general practice in Israel: baseline results from the Israeli Blood Pressure Control (IBPC) program.

R. Viskoper, D. Dicker, D. Gavish, 2003, The Israel Medical Association journal : IMAJ.

Lipoprotein(a) reduction by N-acetylcysteine

J. Breslow, D. Gavish, 1991, The Lancet.

Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts. Normalization with bezafibrate therapy.

S. Eisenberg, O. Stein, Y. Stein, 1985, The Journal of clinical investigation.

In vivo conversion of human HDL3 to HDL2 and apoE-rich HDL1 in the rat: effects of lipid transfer protein.

S. Eisenberg, D. Gavish, Y. Oschry, 1987, Journal of lipid research.

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.

M. Weintraub, J. Breslow, D. Gavish, 1989, Circulation.

The Effect of Lovastatin on Early Restenosis

Y. Neuman, M. Fainaru, Y. Beigel, 1995, Journal of clinical pharmacology.

Cellular metabolism of human plasma intermediate-density lipoprotein (IDL).

S. Eisenberg, T. Vogel, G. Friedman, 1990, Biochimica et biophysica acta.

Heritable allele-specific differences in amounts of apoB and low-density lipoproteins in plasma.

J. Breslow, E. Brinton, D. Gavish, 1989, Science.

Diurnal variations of plasma lipids, tissue and plasma lipoprotein lipase, and VLDL secretion rates in the rat. A model for studies of VLDL metabolism.

S. Eisenberg, E. Shafrir, D. Gavish, 1987, Biochimica et biophysica acta.

Interactions between human and carp (Cyprimus carpio) low density lipoproteins (LDL) and LDL receptors.

M. Schwartz, D. Gavish, A. Harel, 1988, Comparative biochemistry and physiology. B, Comparative biochemistry.

Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.

J. Breslow, D. Gavish, N. Azrolan, 1989, The Journal of clinical investigation.

Intensification of diabetes treatment with long-acting insulin shows no benefit over other diabetes treatment.

D. Gavish, J. Wainstein, E. Leibovitz, 2011, The Israel Medical Association journal : IMAJ.

Lipoprotein(a) in diet-induced atherosclerosis in nonhuman primates.

T. Clarkson, R. Nachman, D. Gavish, 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

Does Metformin Treatment Influence Bone Formation in Patients with Nonalcoholic Fatty Liver Disease?

M. Shargorodsky, D. Gavish, E. Soifer, 2015, Hormone and Metabolic Research.

What is the role of lipoprotein abnormalities and platelet aggregation defects in cardiovascular disease in chronic dialysis patients?

D. Gavish, G. Boner, J. Fuchs, 2006, International Urology and Nephrology.

Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats.

H. Shirin, H. Aeed, R. Bruck, 2013, World journal of gastroenterology.

Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model.

J. Breslow, D. Gavish, N. Azrolan, 1991, The Journal of biological chemistry.

The cadastral mapping of Palestine, 1858-1928

D. Gavish, R. Kark, 1993 .

Cost-utility analysis of a national project to reduce hypertension in Israel

C. Yosefy, R. Viskoper, D. Dicker, 2007, Cost effectiveness and resource allocation : C/E.

The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortality.

C. Yosefy, T. Tulchinsky, D. Dicker, 2003, Preventive medicine.

Bulimia. An underlying behavioral disorder in hyperlipidemic pancreatitis: a prospective multidisciplinary approach.

E. Berry, E. Witztum, E. Leitersdorf, 1987, Archives of internal medicine.

Etiology, Warning Signs and Therapy of Torsade de Pointes: A Study of 10 Patients

A. Keren, S. Gottlieb, D. Tzivoni, 1981, Circulation.

Quinidine-induced hepatitis. A common and reversible hypersensitivity reaction.

I. S. Levij, H. Knobler, D. Gavish, 1986, Archives of internal medicine.

Hepatitis and jaundice associated with measles in young adults. An analysis of 65 cases.

Y. Kleinman, D. Gavish, T. Chajek‐Shaul, 1983, Archives of internal medicine.

Molecular genetics of familial hypercholesterolemia in Israel - revisited.

S. Humphries, D. Harats, V. Meiner, 2017, Atherosclerosis.

Association of Contemporary Statin Pretreatment Intensity and LDL-C Levels on the Incidence of STEMI Presentation

M. Glikson, Z. Iakobishvili, M. Moriel, 2021, Life.

Early and late onset ulcerative colitis: distinct clinical features.

D. Rachmilewitz, D. Gavish, J. Zimmerman, 1985, Journal of clinical gastroenterology.

Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus.

M. Boaz, M. Shargorodsky, Z. Matas, 2007, The American journal of cardiology.

Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?

M. Boaz, M. Shargorodsky, Z. Matas, 2012, Cardiovascular Diabetology.

The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity

M. Boaz, R. Zimlichman,, M. Shargorodsky, 2006, International Journal of Obesity.

The Arad Countryside

D. Alon, D. Gavish, D. Amiran, 1980 .

Change in very low‐, low‐, and high‐density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia

S. Eisenberg, D. Gavish, Y. Oschry, 1986, European journal of clinical investigation.

Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.

R. Pasternak, J. Paolini, M. Davidson, 2009, The American journal of cardiology.

Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.

S. Eisenberg, R. Deckelbaum, D. Gavish, 1984, The Journal of clinical investigation.

Sequence polymorphism in the human apoB gene at position 8344.

J. Breslow, L. Huang, D. Gavish, 1990, Nucleic acids research.

The molecular basis of severe hypertriglyceridemia: from genetic counseling to gene therapy.

D. Gavish, 2013, The Israel Medical Association journal : IMAJ.

Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safety

I. Shapira, D. Gavish, A. Rubinstein, 2000, Journal of internal medicine.

Sitagliptin pretreatment in diabetes patients presenting with acute coronary syndrome: results from the Acute Coronary Syndrome Israeli Survey (ACSIS)

S. Matetzky, S. Gottlieb, I. Goldenberg, 2013, Cardiovascular Diabetology.

Prolonged treatment with the AT1 receptor blocker, valsartan, increases small and large artery compliance in uncomplicated essential hypertension.

R. Zimlichman,, M. Shargorodsky, D. Gavish, 2002, American journal of hypertension.

High dose treatment with angiotensin II receptor blocker in patients with hypertension: differential effect of tissue protection versus blood pressure lowering.

M. Boaz, R. Zimlichman,, M. Shargorodsky, 2008, Atherosclerosis.

Cost-utility analysis of a national project to reduce hypertension in

C. Yosefy, R. Viskoper, D. Dicker, 2015 .

Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program - initial cost utility analysis

C. Yosefy, T. Tulchinsky, D. Dicker, 2003, Blood pressure.

P-438: Relationship between obesity and resistant hypertension

R. Viskoper, D. Dicker, D. Gavish, 2002 .

Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus.

R. Zimlichman,, M. Shargorodsky, Z. Matas, 2003, American journal of hypertension.

MEasuring Nutrition risk in hospitalized patients: MENU, a hospital-based prevalence survey.

M. Boaz, Z. Matas, D. Gavish, 2012, The Israel Medical Association journal : IMAJ.

Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis?

M. Boaz, M. Shargorodsky, Z. Matas, 2009, International Journal of Obesity.

Extent of measles hepatitis in various ages

Z. Ackerman, D. Gavish, Z. Weizman, 1988, Hepatology.

Normal weight diabetic patients versus obese diabetics: relation of overall and abdominal adiposity to vascular health

M. Shargorodsky, D. Gavish, Alla Lukich, 2014, Cardiovascular Diabetology.

Beyond guidelines: achieving the optimum in LDL cholesterol control

D. Harats, D. Gavish, R. Bitzur, 2005, Current opinion in lipidology.

CAPTOPRIL AND PHAEOCHROMOCYTOMA

A. Israeli, R. Melmed, D. Gavish, 1985, The Lancet.

Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia.

R. Zimlichman,, M. Shargorodsky, D. Gavish, 2001, American journal of hypertension.

Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women.

M. Boaz, M. Shargorodsky, Z. Matas, 2009, Atherosclerosis.

The Survey of Palestine Under the British Mandate, 1920-1948

D. Gavish, 2005 .

A Russian naval officer's chart of Haifa Bay (1772)

D. Gavish, Rehav Rubin, M. Frumin, 2002 .

Long-term thyrotropin-suppressive therapy with levothyroxine impairs small and large artery elasticity and increases left ventricular mass in patients with thyroid carcinoma.

R. Zimlichman,, M. Shargorodsky, D. Gavish, 2006, Thyroid : official journal of the American Thyroid Association.

Genetic and non-genetic control of apoprotein

S. Eisenberg, Y. Kleinman, G. Friedman, 1987 .

Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patients.

M. Boaz, M. Shargorodsky, Z. Matas, 2008, Atherosclerosis.

Persistent anemia in otherwise asymptomatic severe aortic stenosis: a possible indication for valve replacement?

D. Gavish, D. Harpaz, E. Leibovitz, 2004, The Israel Medical Association journal : IMAJ.

Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease.

M. Shargorodsky, D. Gavish, E. Omelchenko, 2014, Journal of the American Society of Hypertension : JASH.

Treatment of hypertension with thiazides: benefit or damage-effect of low- and high-dose thiazide diuretics on arterial elasticity and metabolic parameters in hypertensive patients with and without glucose intolerance.

M. Boaz, R. Zimlichman,, M. Shargorodsky, 2007, Journal of the cardiometabolic syndrome.

Guillain-Barré syndrome: a possible extraintestinal manifestation of ulcerative colitis.

D. Gavish, J. Zimmerman, Z. Argov, 1985, Journal of clinical gastroenterology.

Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors.

M. Shargorodsky, Z. Matas, R. Cernes, 2008, Bone.

Cardiovascular risk assessment and treatment to target low density lipoprotein levels in hospitalized ischemic heart disease patients: results of the HOLEM study.

U. Goldbourt, D. Harats, Y. Gerber, 2005, The Israel Medical Association journal : IMAJ.

Infection with Streptococcus milleri.

R. Raz, M. Ephros, D. Gavish, 1987, The Journal of infection.

Cholestatic jaundice, an unusual side effect of etretinate.

A. Israeli, K. Holubar, D. Gavish, 1985, Journal of the American Academy of Dermatology.

Follow-up in a lipid clinic improves the management of risk factors in cardiovascular disease patients.

R. Zimlichman,, M. Shargorodsky, D. Gavish, 2002, The Israel Medical Association journal : IMAJ.

Etiology, Warning Signs and Therapy of Torsade de Pointes: A Study of 10 Patients

A. Keren, S. Gottlieb, D. Tzivoni, 1981, Circulation.

Molecular genetics of familial hypercholesterolemia in Israel-revisited.

D. Harats, V. Meiner, R. Durst, 2017, Atherosclerosis.

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

Pedro F. Campos, Luciano Lopes de Sousa, Howard D. Rubenstein, 2023, European heart journal.

Effect of long‐term treatment with rosiglitazone on arterial elasticity and metabolic parameters in patients with Type 2 diabetes mellitus: a 2‐year follow‐up study

M. Boaz, R. Zimlichman,, M. Shargorodsky, 2007, Diabetic medicine : a journal of the British Diabetic Association.